Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Safety and Anti-Tumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Craig H. Moskowitz, Mariana Bastos-Oreiro, MD PhD, David Ungar, MD, Ilva Dautaj, Matko Kalac, MD PhD

Blood (2019) 134 (Supplement_1): 2807.

https://doi.org/10.1182/blood-2019-128036

Published: 2019

Journal Articles

Mini BEAM with Full-Dose of Melphalan (beaM) As a Conditioning Regimen for High Risk Patients with NHL Undergoing Autologous SCT

Matko Kalac, MD PhD, Cristine Candland, RN, Lisa Wallace, RN, Elizabeth Gentner, RN, Shreya Shah, Jennifer E Amengual, MD, Changchun Deng, MD PhD, Suzanne Lentzsch, MD PhD, Owen A. O'Connor, MD PhD, Markus Y Mapara, MD PhD

Blood (2016) 128 (22): 5834.

https://doi.org/10.1182/blood.V128.22.5834.5834

Published: 2016

Journal Articles

Targeting NF-κB with First in Class N-Quinoline Benzenesulfonamides (NQBS) Reveals Potent Activity in Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Matko Kalac, MD PhD, Michael Mangone, PhD, Alison Rinderspacher, PhD, Shi-Xian Deng, PhD, Luigi Scotto, PhD, Jeremie Vendome, PhD, Mukesh Bansal, PhD, Andrea Califano, PhD, Donald Landry, MD PhD, Owen A. O'Connor, MD PhD

Blood (2015) 126 (23): 4435.

https://doi.org/10.1182/blood.V126.23.4435.4435

Published: 2015

Journal Articles

Sirtuin Inhibition in Combination with Histone Deacetylase (HDAC) Inhibition Is Effective Therapy for Aggressive B-Cell Lymphomas in Both Pre-Clinical and Clinical Studies of Disease.

Jennifer E Amengual, MD, Sean Clark-Garvey, Matko Kalac, MD, PhD, Luigi Scotto, PhD, Enrica Marchi, MD, PhD, Celests Rojas, Ellen Neylon, FNP, MSN, RN, OCN, Paul M Johannet, Salvia Jain, MD, Jasmine M. Zain, MD, Owen A. O'Connor, MD, PhD

Blood (2012) 120 (21): 2725.

https://doi.org/10.1182/blood.V120.21.2725.2725

Published: 2012

Journal Articles

Validation of a Novel Bioluminescent Mouse Model of Sezary Syndrome for Preclinical Drug Screening

Salvia Jain, MD, Luigi Scotto, Ph.D., Enrica Marchi, MD, Ph.D., Matko Kalac, MD, Ph.D., Jennifer Amengual, M.D., Jairo Baquero Buitrago, Owen A. O'Connor, MD, PhD

Blood (2011) 118 (21): 2725.

https://doi.org/10.1182/blood.V118.21.2725.2725

Published: 2011

Journal Articles

Combination of Epigenetic Agents Synergistically Reverse the Malignant Phenotype in Models of T-Cell Lymphoma

Enrica Marchi, MD, Ph.D., Matko Kalac, MD, Ph.D., Danielle C Bongero, Christine M McIntosh, Laura K Fogli, Luigi Scotto, Ph.D., Maura Rossi, Ph.D., Pier Luigi Zinzani, MD, PhD, Stefano Pileri, MD, Pier Paolo Piccaluga, Sr., MD, PhD, Owen A. O'Connor, MD, PhD

Blood (2011) 118 (21): 2727.

https://doi.org/10.1182/blood.V118.21.2727.2727

Published: 2011

Journal Articles

Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma,

Jennifer E Amengual, MD, Matko Kalac, MD, Ph.D., Luigi Scotto, Ph.D., Patrick A Sleckman, Enrica Marchi, MD, Ph.D., Changchun Deng, MD, PhD, Danielle C Bongero, Salvia Jain, MD, Jairo Baquero Buitrago, Owen A. O'Connor, MD, PhD

Blood (2011) 118 (21): 3733.

https://doi.org/10.1182/blood.V118.21.3733.3733

Published: 2011

Journal Articles

The Combination of Histone Deacetylase Inhibitors and Hypomethylating Agents Exhibits Marked Synergy In Preclinical Models of T-Cell Lymphoma

Enrica Marchi, MD, Ph, D, Danielle C Bongero, Matko Kalac, MD, PhD, Luigi Scotto, Ph.D., Owen A. O'Connor, MD, PhD

Blood (2010) 116 (21): 3937.

https://doi.org/10.1182/blood.V116.21.3937.3937

Published: 2010

Journal Articles

Generation and Characterization of a Novel CD19-CherryLuciferase (CD19CL) Mouse Model: A New Fluorescent/Bioluminescent Model for the Study of B-Cell Development and Lymphomagenesis

Luigi Scotto, Ph.D., Marianna Kruithof de Julio, Ph.D., Luca Paoluzzi, MD, Matko Kalac, MD, Ph.D., Enrica Marchi, MD, Ph.D., Jairo Baquero Buitrago, BS, Owen A. O'Connor, MD, Ph.D.

Blood (2010) 116 (21): 3940.

https://doi.org/10.1182/blood.V116.21.3940.3940

Published: 2010

Journal Articles

Histone Deacetylase Inhibitors Synergistically Enhance the Cytotoxic Effect of Hypomethylating Agents in Models of Diffuse Large B-Cell Lymphoma.

Matko Kalac, MD, Yukiko Kitagawa, MD, PhD, Seshan Ennapadam Venkatraman, Benjamin Tycko, MD, PhD, Owen A O'Connor, MD, PhD

Blood (2009) 114 (22): 3720.

https://doi.org/10.1182/blood.V114.22.3720.3720

Published: 2009

NARROW

Safety and Anti-Tumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Mini BEAM with Full-Dose of Melphalan (beaM) As a Conditioning Regimen for High Risk Patients with NHL Undergoing Autologous SCT

Targeting NF-κB with First in Class N-Quinoline Benzenesulfonamides (NQBS) Reveals Potent Activity in Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Sirtuin Inhibition in Combination with Histone Deacetylase (HDAC) Inhibition Is Effective Therapy for Aggressive B-Cell Lymphomas in Both Pre-Clinical and Clinical Studies of Disease.

Validation of a Novel Bioluminescent Mouse Model of Sezary Syndrome for Preclinical Drug Screening

Combination of Epigenetic Agents Synergistically Reverse the Malignant Phenotype in Models of T-Cell Lymphoma

Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma,

The Combination of Histone Deacetylase Inhibitors and Hypomethylating Agents Exhibits Marked Synergy In Preclinical Models of T-Cell Lymphoma

Generation and Characterization of a Novel CD19-CherryLuciferase (CD19CL) Mouse Model: A New Fluorescent/Bioluminescent Model for the Study of B-Cell Development and Lymphomagenesis

Histone Deacetylase Inhibitors Synergistically Enhance the Cytotoxic Effect of Hypomethylating Agents in Models of Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only